Results of Vincristine, Cyclophosphamide and Topotecan Protocol in Refractory/Relapsed Pediatric Solid Tumors: A Single-center Experience
Journal Title: The Journal of Pediatric Research - Year 2019, Vol 6, Issue 3
Abstract
Aim: Despite dramatic progress in the treatment of pediatric solid tumors in the last 3 decades, confronting a relapsed or refractory patient is still challenging. We report our experience of refractory/relapsed pediatric solid tumor patients treated with vincristin + topotecan + cyclophosphamide (VTC) as a salvage therapy. Materials and Methods: Eleven refractory/relapsed patients (5 neuroblastoma, 4 Ewing’s sarcoma, 1 rhabdomyosarcoma and 1 osteosarcoma) who were given VTC as a salvage therapy were evaluated. All of them were metastatic at diagnosis and received appropriate initial chemotherapy. VTC consisted of vincristin (1.5 mg/m2 on day 1), cyclophosphamide (600 mg/m2/day with mesna, on days 1 and 2) and topotecan (1 mg/m2/day on days 1, 2 and 3). Results: Eleven patients received a total of 53 courses of VTC with a median of 4 (range: 2-14). Median age at diagnosis was 12 years. One patient achieved complete response, 6 patients had stable disease, and 4 patients had progressive disease after 2 courses of VTC. The median survival duration was 28 months after diagnosis while it was 16 months after relapse. The median survival duration after first VTC was 5 months (2-21 months). Myelosuppression was the primary dose limiting toxicity. Conclusion: We concluded that VTC has a clinically tolerable but non-satisfactory effect on relapsed/refractory solid tumors in children.
Authors and Affiliations
Uğur Demirsoy, Funda Çorapçıoğlu, Meriban Karadoğan
Keywords
Related Articles
- EP ID EP656804
- DOI 10.4274/jpr.galenos.2018.80774
- Views 82
- Downloads 0
Effects of Chronic Gastritis on Sleep and Quality of Life in Adolescents
Aim: This study aims to evaluate the sleep quality and the quality of life (QoL) of adolescents with chronic gastritis, and determine the related factors. Materials and Methods: This study included patients who were diag...
Nutritional Habits and Precocious Puberty in Girls: A Pilot Study
Aim: Precocious puberty (PP) is defined as the appearance of secondary sexual characteristics before the age of nine in boys or eight in girls. Due to changing socio-economic conditions, nutritional habits and environmen...
Congenital Heart Diseases Detected by Prenatal Fetal Echocardiography and Associated Extracardiac Anomalies
Aim: The aim of this study is to determine the relationship between extracardiac abnormalities and congenital heart diseases in fetuses that were referred for fetal echocardiography due to a variety of reasons. Materials...
Orofacial Crohn’s Disease: A Case Report
Crohn’s disease (CD) is a chronic disease of the digestive system. It is characterized by lesions predominantly located in the small intestine and colon, although they may also occur in any segment of the gut, including...
The Effect of Gonadotropin-releasing Hormone Analog Treatment on Body Mass Index and Height in Female Patients with Central Precocious Puberty
Aim: Gonadotropin-releasing hormone agonists (GnRHa) are widely used in the treatment of central precocious puberty (CPP). There is concern that GnRHa treatment, whose positive effects on the adult height are known, may...